| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |